Healthcare -
Biotechnology - NASDAQ - US
$ 3.345
1.36 %
$ 634 M
Market Cap
-7.78
P/E
ABUS - OPERATING EXPENSES
Operating Expenses ABUS - Arbutus Biopharma Corporation
96.2 M
LAST VALUE
7.92%
2 YEAR CAGR
4.81%
5 YEAR CAGR
13.30%
10 YEAR CAGR